Log In
Print
BCIQ
Print
Print this Print this
 

OMS302

  Manage Alerts
Collapse Summary General Information
Company Omeros Corp.
DescriptionCombination of ketorolac, an anti-inflammatory agent, and phenylephrine, a pupil dilating agent
Molecular Target Cyclooxygenases (COX) ; Adrenergic receptor alpha 1 (ADRA1)
Mechanism of Action 
Latest Stage of DevelopmentPhase III
IndicationCataract
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today